Acute Coronary Syndrome
Mortality rate doubles with weekend vs. weekday admission for patients with ACS, HF
Adults with ACS and acute decompensated HF are twice as likely to die of any cause within 1 year if admitted on weekends or holidays vs. weekdays, independent of age or hemodynamic status or traditional CV risk factors, researchers reported.
Statins for primary prevention provide similar protection among older vs. younger adults
Older individuals appeared to derive similar magnitude of LDL lowering and CV risk reduction from statin therapy initiation vs. younger patients, according to data from a large Danish study.
Inorganic dietary nitrate lowers contrast-induced acute kidney injury from angiogram
A short course of inorganic dietary nitrate reduced contrast-induced kidney injury in high-risk patients with non-ST segment elevation ACS referred for invasive coronary angiography, researchers reported.
Extended clopidogrel strategy prevents adverse events in ‘bi-risk’ patients with ACS
Extended clopidogrel monotherapy after 9-to-12-month dual antiplatelet therapy reduced risk for adverse events in patients with ACS at increased bleeding and ischemic risk who underwent drug-eluting stent implantation, a speaker reported.
FDA designates recall of two intra-aortic balloon pumps as class I
The FDA announces a recall of intra-aortic balloon pumps manufactured by Datascope/Maquet/Getinge due to risk for unexpected shutdown due to electrical failure in the power management or solenoid boards.
Complete revascularization likely improves HF risk in those with ACS plus multivessel CAD
Complete revascularization was associated with reduced HF hospitalization and both CV and all-cause death among patients presenting with ACS and multivessel CAD, researchers reported in the Journal of the American Heart Association.
Malnutrition predicts in-hospital death risk for women admitted for heart attack
Women admitted with ACS at risk for malnutrition had a more than sixfold higher odds for in-hospital mortality compared with women not at malnutrition risk, researchers reported.
Ezetimibe did not increase diabetes risk in IMPROVE-IT substudy
Researchers observed no increased risk for new-onset diabetes among IMPROVE-IT participants assigned to ezetimibe plus statin therapy vs. statin monotherapy, according to a research letter.
HOST-IDEA
Comparing single antiplatelet therapy after 3-month DAPT with 12-month DAPT after PCI with third-generation DES with the thinnest struts.
Metabolic syndrome with sleep apnea ups risk for heart events in hospitalized women
Women hospitalized with acute coronary syndrome who have metabolic syndrome are 1.7 times more likely to experience a major adverse CV or cerebrovascular event if they also have comorbid obstructive sleep apnea, researchers reported.